+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biobanks Market - Global Forecast 2026-2032- Product Image
Biobanks Market - Global Forecast 2026-2032- Product Image
Sale

Biobanks Market - Global Forecast 2026-2032

  • Report

  • 195 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6082867
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Biobanks Market is projected to reach USD 89.72 Billion in 2026. It is expected to continue growing at a CAGR of 11.45%, reaching USD 175.29 Billion by 2032.

Biobanks have become critical infrastructure for precision medicine, drug discovery, population health research, and translational diagnostics. By collecting, processing, storing, and governing human biospecimens alongside linked clinical, genomic, imaging, lifestyle, and longitudinal data, modern biobanks help researchers identify disease mechanisms, validate biomarkers, and develop targeted therapies with stronger real-world relevance.

Demand is being shaped by the expansion of genomics, oncology research, rare disease programs, immunology, regenerative medicine, and public health surveillance. Large-scale initiatives such as UK Biobank, with approximately 500,000 participants, and the U.S. All of Us Research Program, designed to enroll one million or more participants, demonstrate how population-scale biospecimen and data resources are becoming foundational to evidence-based healthcare innovation.

Transformative Shifts in the Biobanks Landscape

The biobanks landscape is shifting from specimen-centered repositories to data-rich, interoperable research platforms. Organizations are prioritizing standardized pre-analytical workflows, automated sample handling, cold-chain integrity, digital consent, and harmonized metadata to improve sample quality and reproducibility across multi-site studies.

A second major shift is the rise of participant-centric and disease-specific biobanking. Patients are increasingly engaged through dynamic consent models, return-of-results discussions, and governance frameworks that emphasize privacy, transparency, and equitable access. This is especially important as biobanks support multi-omics research, real-world evidence generation, and clinical trial matching for precision oncology, cardiometabolic disease, neurodegeneration, and infectious disease studies.

Cumulative Impact of Artificial Intelligence on Biobanks

Artificial intelligence is accelerating the value of biobanks by improving sample annotation, cohort discovery, quality control, and predictive analytics. AI-enabled tools can help researchers identify suitable specimens faster by searching structured and unstructured clinical data, genomic variants, pathology images, and longitudinal outcomes, reducing the time required to build high-quality research cohorts.

The cumulative impact is strongest when AI is paired with robust governance and interoperable data standards. Machine learning can support biomarker discovery, disease-risk modeling, and clinical trial feasibility, but its performance depends on representative datasets, clear provenance, bias monitoring, and privacy-preserving methods such as federated learning. As a result, leading biobanks are investing in data curation, secure analytics environments, and FAIR data principles to ensure AI outputs remain auditable and clinically credible.

Key Regional Insights

North America remains a leading biobanking region due to deep investment in biomedical research, mature academic medical centers, large health systems, and national precision medicine programs. The United States benefits from NIH-supported infrastructure, disease-focused repositories, and large longitudinal programs, while Canada’s public health and genomics initiatives support population-level research, Indigenous data governance considerations, and strong ethical oversight.

Europe is distinguished by coordinated research networks, GDPR-driven data protection, and cross-border initiatives that encourage harmonized standards across clinical research and population health. Asia-Pacific is expanding as China, Japan, India, South Korea, Singapore, and Australia build genomic medicine capabilities, national biobank assets, and hospital-linked biospecimen networks. Latin America, the Middle East, and Africa are gaining strategic importance because their diverse populations can improve global disease understanding, although investment in cold-chain infrastructure, consent harmonization, workforce training, and sustainable research funding remains uneven across markets.

Key Group Insights

Within ASEAN, biobanking development is linked to expanding biomedical research capacity, infectious disease surveillance, cancer research, and genomics programs in countries such as Singapore, Thailand, Malaysia, Indonesia, and Vietnam. The GCC is investing in precision medicine and population health as part of broader healthcare modernization, with national genome initiatives, academic medical partnerships, and health data strategies supporting biobank development.

The European Union provides one of the most structured environments for cross-border biobank collaboration through data protection rules, research funding frameworks, and infrastructure networks that promote interoperability and ethical access. BRICS countries are important because they combine large populations, genetic diversity, and rising biotechnology investment, although regulatory maturity and data-sharing practices vary. G7 countries continue to set benchmarks in data governance, translational research, and pharmaceutical partnerships, while NATO countries increasingly recognize biobanking relevance for biodefense, public health resilience, and pandemic preparedness.

Key Country Insights

The United States leads through extensive NIH-funded repositories, cancer and rare disease collections, academic medical centers, and the All of Us Research Program. Canada emphasizes population health, ethics, and genomics collaboration, while Mexico and Brazil are strengthening cancer, infectious disease, and population diversity research. In Europe, the United Kingdom’s UK Biobank is a global reference model, while Germany, France, Italy, and Spain maintain strong clinical research networks, population cohorts, and disease-specific repositories; Russia has scientific capacity but faces more complex international collaboration dynamics.

China is scaling biobanking through major hospitals, genomics research, and national precision medicine priorities, while India’s large and diverse population creates significant opportunity for population genomics, newborn screening research, and disease-specific repositories. Japan and South Korea are advanced in precision medicine, aging research, oncology, and high-quality clinical data integration. Australia combines population health expertise, longitudinal cohorts, Indigenous health governance considerations, and strong research ethics frameworks, supporting its role as a major Asia-Pacific biobanking hub.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize biospecimen quality, standardized operating procedures, and interoperable metadata because sample integrity directly affects downstream research reliability. Investments in laboratory automation, temperature monitoring, chain-of-custody systems, validated storage protocols, and internationally recognized quality management practices can reduce variability and improve trust among academic, clinical, and pharmaceutical partners.

Executives should also strengthen data governance by adopting dynamic consent, privacy-by-design architecture, controlled access committees, and transparent benefit-sharing practices. To compete in AI-enabled biobanking, organizations should build secure analytics environments, curate high-quality linked datasets, align with FAIR principles, and develop partnerships with hospitals, contract research organizations, diagnostics developers, and biopharmaceutical companies.

Research Methodology

This executive summary is based on secondary research from publicly available biomedical research programs, government health agencies, peer-reviewed literature, national genomics initiatives, regulatory frameworks, and documented biobank infrastructure models. The assessment emphasizes verifiable indicators such as established population cohorts, national precision medicine programs, recognized data governance requirements, ethical guidelines, and documented regional healthcare investment patterns.

The methodology applies qualitative triangulation across scientific, regulatory, operational, and commercial sources to identify consistent trends in biobanking demand, technology adoption, AI integration, and geographic expansion. Insights are structured to support strategic planning for biobank operators, pharmaceutical companies, academic research centers, healthcare systems, diagnostics firms, and investors evaluating the global biobanks landscape without relying on market sizing, market share, or forecasting assumptions.

Conclusion

Biobanks are evolving into strategic engines for precision medicine, data-driven drug development, and population health intelligence. Their value increasingly depends on the ability to combine high-quality biospecimens with validated clinical data, advanced analytics, ethical governance, and scalable collaboration models.

Organizations that invest in automation, AI-ready data infrastructure, global standards, and participant trust will be best positioned to capture long-term opportunities. As genomics, multi-omics, and real-world evidence become central to healthcare innovation, biobanks will remain indispensable to the future of biomedical discovery and personalized care.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Biobanks Market, by Type
7.1. Introduction
7.2. Disease-Oriented Biobanks
7.3. Genomic-Based Biobanks
7.4. Population-Based Biobanks
7.5. Virtual Biobanks
8. Biobanks Market, by Component
8.1. Introduction
8.2. Consumables
8.3. Equipment
8.3.1. Incubators & Centrifuges
8.3.2. Monitoring Systems
8.3.3. Temperature Control Systems
8.3.3.1. Cryogenic Storage Systems
8.3.3.2. Freezers & Refrigerators
8.3.3.3. Thawing Equipment
8.4. Services
8.4.1. Data Management
8.4.2. Sample Analysis
8.4.3. Storage & Processing
8.4.4. Transport
9. Biobanks Market, by Sample Type
9.1. Introduction
9.2. Blood Derivatives
9.3. Cell Lines
9.4. Nucleic Acid
9.5. Tissues
10. Biobanks Market, by Application
10.1. Introduction
10.2. Clinical Diagnostics
10.3. Personalized Medicine
10.4. Research
10.5. Therapeutics
10.5.1. Drug Development
10.5.2. Gene Editing
11. Biobanks Market, by End User
11.1. Introduction
11.2. Academic Institutions
11.3. Contract Research & Manufacturing Organizations
11.4. Hospitals
11.5. Pharmaceutical & Biotech Companies
12. Biobanks Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Biobanks Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Biobanks Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Acorn Biolabs Inc.
16.2. Anuva
16.3. ASKION GmbH
16.4. Avantor, Inc.
16.5. Azenta Life Science
16.6. Bay Biosciences LLC
16.7. Beckman Coulter, Inc. by Danaher Corporation
16.8. Becton, Dickinson and Company
16.9. BioIVT, LLC
16.10. BioKryo by L’AIR LIQUIDE S.A.
16.11. BioLife Solutions Inc.
16.12. BocaBio
16.13. Bruker Corporation
16.14. CELLIVIA 3 S.A.
16.15. Celltex Therapeutics Corporation
16.16. Charles River Laboratories International, Inc.
16.17. Cryoport Systems, LLC
16.18. CTIBiotech by Swedish Orphan Biovitrum AB
16.19. Cureline, Inc
16.20. Firalis Group
16.21. Greiner Bio-One International GmbH
16.22. Hamilton Company
16.23. Hope Biosciences, LLC
16.24. Lonza Group Ltd.
16.25. LVL technologies GmbH & Co. KG.
16.26. Merck KGaA
16.27. Precision Cellular Storage Ltd.
16.28. ProteoGenex, Inc.
16.29. Provia Laboratories, Inc.
16.30. Qiagen N.V.
16.31. Standard BioTools Inc.
16.32. STEMCELL Technologies
16.33. Tecan Trading AG
16.34. Thermo Fisher Scientific Inc.
16.35. UK Biobank Limited
List of Figures
FIGURE 1. GLOBAL BIOBANKS MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL BIOBANKS MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL BIOBANKS MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL BIOBANKS MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL BIOBANKS MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2025 VS 2032 (%)
FIGURE 9. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL BIOBANKS MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL BIOBANKS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL BIOBANKS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL BIOBANKS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL BIOBANKS MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL BIOBANKS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL DISEASE-ORIENTED BIOBANKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL DISEASE-ORIENTED BIOBANKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL DISEASE-ORIENTED BIOBANKS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL GENOMIC-BASED BIOBANKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL GENOMIC-BASED BIOBANKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL GENOMIC-BASED BIOBANKS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL POPULATION-BASED BIOBANKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL POPULATION-BASED BIOBANKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL POPULATION-BASED BIOBANKS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL VIRTUAL BIOBANKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL VIRTUAL BIOBANKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL VIRTUAL BIOBANKS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL EQUIPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL INCUBATORS & CENTRIFUGES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL INCUBATORS & CENTRIFUGES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL INCUBATORS & CENTRIFUGES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL MONITORING SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL MONITORING SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL TEMPERATURE CONTROL SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL TEMPERATURE CONTROL SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL TEMPERATURE CONTROL SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL CRYOGENIC STORAGE SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL CRYOGENIC STORAGE SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL CRYOGENIC STORAGE SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL FREEZERS & REFRIGERATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL FREEZERS & REFRIGERATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL FREEZERS & REFRIGERATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL THAWING EQUIPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL THAWING EQUIPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL THAWING EQUIPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL DATA MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL DATA MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL DATA MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL SAMPLE ANALYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL SAMPLE ANALYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL SAMPLE ANALYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL STORAGE & PROCESSING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL STORAGE & PROCESSING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL STORAGE & PROCESSING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL TRANSPORT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL TRANSPORT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL TRANSPORT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL BLOOD DERIVATIVES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL BLOOD DERIVATIVES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL BLOOD DERIVATIVES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL CELL LINES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL CELL LINES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL CELL LINES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL NUCLEIC ACID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL NUCLEIC ACID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL NUCLEIC ACID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL TISSUES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL TISSUES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL TISSUES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL PERSONALIZED MEDICINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL RESEARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL RESEARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL RESEARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL THERAPEUTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL THERAPEUTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL THERAPEUTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL DRUG DEVELOPMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL DRUG DEVELOPMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL DRUG DEVELOPMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL GENE EDITING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL GENE EDITING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL GENE EDITING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL ACADEMIC INSTITUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL CONTRACT RESEARCH & MANUFACTURING ORGANIZATIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL CONTRACT RESEARCH & MANUFACTURING ORGANIZATIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL CONTRACT RESEARCH & MANUFACTURING ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL PHARMACEUTICAL & BIOTECH COMPANIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL BIOBANKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 104. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 105. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 106. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 107. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 108. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 109. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 112. NORTH AMERICA BIOBANKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 113. NORTH AMERICA BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 114. NORTH AMERICA BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 115. NORTH AMERICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 116. NORTH AMERICA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 117. NORTH AMERICA BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 119. NORTH AMERICA BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 120. NORTH AMERICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 121. NORTH AMERICA BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 122. LATIN AMERICA BIOBANKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. LATIN AMERICA BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 124. LATIN AMERICA BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 125. LATIN AMERICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 126. LATIN AMERICA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 127. LATIN AMERICA BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 128. LATIN AMERICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 129. LATIN AMERICA BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 130. LATIN AMERICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 131. LATIN AMERICA BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 132. EUROPE BIOBANKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. EUROPE BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 134. EUROPE BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 135. EUROPE BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 136. EUROPE BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 137. EUROPE BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 138. EUROPE BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 139. EUROPE BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 140. EUROPE BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 141. EUROPE BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 142. MIDDLE EAST BIOBANKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. MIDDLE EAST BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 144. MIDDLE EAST BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 145. MIDDLE EAST BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 146. MIDDLE EAST BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 147. MIDDLE EAST BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 148. MIDDLE EAST BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 149. MIDDLE EAST BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 150. MIDDLE EAST BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 151. MIDDLE EAST BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 152. AFRICA BIOBANKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 153. AFRICA BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 154. AFRICA BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 155. AFRICA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 156. AFRICA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 157. AFRICA BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 158. AFRICA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 159. AFRICA BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 160. AFRICA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 161. AFRICA BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL BIOBANKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 163. ASEAN BIOBANKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 164. ASEAN BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 165. ASEAN BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 166. ASEAN BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 167. ASEAN BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 168. ASEAN BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 169. ASEAN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 170. ASEAN BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 171. ASEAN BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 172. ASEAN BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 173. GCC BIOBANKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 174. GCC BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 175. GCC BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 176. GCC BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 177. GCC BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 178. GCC BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 179. GCC BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 180. GCC BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 181. GCC BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 182. GCC BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION BIOBANKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 193. BRICS BIOBANKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 194. BRICS BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 195. BRICS BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 196. BRICS BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 197. BRICS BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 198. BRICS BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 199. BRICS BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 200. BRICS BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 201. BRICS BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 202. BRICS BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 203. G7 BIOBANKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 204. G7 BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 205. G7 BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 206. G7 BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 207. G7 BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 208. G7 BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 209. G7 BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 210. G7 BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 211. G7 BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 212. G7 BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 213. NATO BIOBANKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 214. NATO BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 215. NATO BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 216. NATO BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 217. NATO BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 218. NATO BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 219. NATO BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 220. NATO BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 221. NATO BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 222. NATO BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 223. GLOBAL BIOBANKS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 224. UNITED STATES BIOBANKS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 225. UNITED STATES BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 226. UNITED STATES BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 227. UNITED STATES BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 228. UNITED STATES BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 229. UNITED STATES BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 230. UNITED STATES BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 231. UNITED STATES BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 232. UNITED STATES BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 233. UNITED STATES BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 234. CANADA BIOBANKS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 235. CANADA BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 236. CANADA BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 237. CANADA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 238. CANADA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 239. CANADA BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 240. CANADA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 241. CANADA BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 242. CANADA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 243. CANADA BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 244. MEXICO BIOBANKS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 245. MEXICO BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 246. MEXICO BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 247. MEXICO BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 248. MEXICO BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 249. MEXICO BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 250. MEXICO BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 251. MEXICO BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 252. MEXICO BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 253. MEXICO BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 254. BRAZIL BIOBANKS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 255. BRAZIL BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 256. BRAZIL BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 257. BRAZIL BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 258. BRAZIL BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 259. BRAZIL BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 260. BRAZIL BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 261. BRAZIL BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 262. BRAZIL BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 263. BRAZIL BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 264. UNITED KINGDOM BIOBANKS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 265. UNITED KINGDOM BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 266. UNITED KINGDOM BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 267. UNITED KINGDOM BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 268. UNITED KINGDOM BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 269. UNITED KINGDOM BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 270. UNITED KINGDOM BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 271. UNITED KINGDOM BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 272. UNITED KINGDOM BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 273. UNITED KINGDOM BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 274. GERMANY BIOBANKS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 275. GERMANY BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 276. GERMANY BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 277. GERMANY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 278. GERMANY BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 279. GERMANY BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 280. GERMANY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 281. GERMANY BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 282. GERMANY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 283. GERMANY BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 284. FRANCE BIOBANKS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 285. FRANCE BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 286. FRANCE BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 287. FRANCE BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 288. FRANCE BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 289. FRANCE BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 290. FRANCE BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 291. FRANCE BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 292. FRANCE BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 293. FRANCE BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 294. RUSSIA BIOBANKS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 295. RUSSIA BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 296. RUSSIA BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 297. RUSSIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 298. RUSSIA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 299. RUSSIA BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 300. RUSSIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 301. RUSSIA BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 302. RUSSIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 303. RUSSIA BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 304. ITALY BIOBANKS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 305. ITALY BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 306. ITALY BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 307. ITALY BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 308. ITALY BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 309. ITALY BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 310. ITALY BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 311. ITALY BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 312. ITALY BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 313. ITALY BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 314. SPAIN BIOBANKS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 315. SPAIN BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 316. SPAIN BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 317. SPAIN BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 318. SPAIN BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 319. SPAIN BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 320. SPAIN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 321. SPAIN BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 322. SPAIN BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 323. SPAIN BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 324. CHINA BIOBANKS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 325. CHINA BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 326. CHINA BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 327. CHINA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 328. CHINA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 329. CHINA BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 330. CHINA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 331. CHINA BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 332. CHINA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 333. CHINA BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 334. INDIA BIOBANKS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 335. INDIA BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 336. INDIA BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 337. INDIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 338. INDIA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 339. INDIA BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 340. INDIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 341. INDIA BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 342. INDIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 343. INDIA BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 344. JAPAN BIOBANKS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 345. JAPAN BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 346. JAPAN BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 347. JAPAN BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 348. JAPAN BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 349. JAPAN BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 350. JAPAN BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 351. JAPAN BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 352. JAPAN BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 353. JAPAN BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 354. AUSTRALIA BIOBANKS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 355. AUSTRALIA BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 356. AUSTRALIA BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 357. AUSTRALIA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 358. AUSTRALIA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 359. AUSTRALIA BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 360. AUSTRALIA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 361. AUSTRALIA BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 362. AUSTRALIA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 363. AUSTRALIA BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 364. SOUTH KOREA BIOBANKS MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 365. SOUTH KOREA BIOBANKS MARKET SIZE, BY TYPE, 2017-2032 (USD MILLION)
TABLE 366. SOUTH KOREA BIOBANKS MARKET SIZE, BY COMPONENT, 2017-2032 (USD MILLION)
TABLE 367. SOUTH KOREA BIOBANKS MARKET SIZE, BY EQUIPMENT, 2017-2032 (USD MILLION)
TABLE 368. SOUTH KOREA BIOBANKS MARKET SIZE, BY TEMPERATURE CONTROL SYSTEMS, 2017-2032 (USD MILLION)
TABLE 369. SOUTH KOREA BIOBANKS MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 370. SOUTH KOREA BIOBANKS MARKET SIZE, BY SAMPLE TYPE, 2017-2032 (USD MILLION)
TABLE 371. SOUTH KOREA BIOBANKS MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 372. SOUTH KOREA BIOBANKS MARKET SIZE, BY THERAPEUTICS, 2017-2032 (USD MILLION)
TABLE 373. SOUTH KOREA BIOBANKS MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 374. GLOBAL BIOBANKS MARKET SHARE, BY KEY PLAYER, 2025
TABLE 375. GLOBAL BIOBANKS MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Acorn Biolabs Inc.
  • Anuva
  • ASKION GmbH
  • Avantor, Inc.
  • Azenta Life Science
  • Bay Biosciences LLC
  • Beckman Coulter, Inc. by Danaher Corporation
  • Becton, Dickinson and Company
  • BioIVT, LLC
  • BioKryo by L’AIR LIQUIDE S.A.
  • BioLife Solutions Inc.
  • BocaBio
  • Bruker Corporation
  • CELLIVIA 3 S.A.
  • Celltex Therapeutics Corporation
  • Charles River Laboratories International, Inc.
  • Cryoport Systems, LLC
  • CTIBiotech by Swedish Orphan Biovitrum AB
  • Cureline, Inc
  • Firalis Group
  • Greiner Bio-One International GmbH
  • Hamilton Company
  • Hope Biosciences, LLC
  • Lonza Group Ltd.
  • LVL technologies GmbH & Co. KG.
  • Merck KGaA
  • Precision Cellular Storage Ltd.
  • ProteoGenex, Inc.
  • Provia Laboratories, Inc.
  • Qiagen N.V.
  • Standard BioTools Inc.
  • STEMCELL Technologies
  • Tecan Trading AG
  • Thermo Fisher Scientific Inc.
  • UK Biobank Limited

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 89.72 Billion
Forecasted Market Value ( USD ) by 2032 $ 175.29 Billion
Compound Annual Growth Rate11.4%
Regions CoveredGlobal
No. of Companies Mentioned35

Related Topics

Related Reports

Biobanks Market Size, Share & Trends Analysis Report by Product & Services (LIMS, Biobanking Equipment), Biospecimen Type (Organs, Stem Cells), Biobank Type (Real, Virtual), Service, Application, and Region with Growth Forecasts, 2026-2033 - Product Image

Biobanks Market Size, Share & Trends Analysis Report by Product & Services (LIMS, Biobanking Equipment), Biospecimen Type (Organs, Stem Cells), Biobank Type (Real, Virtual), Service, Application, and Region with Growth Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Biobanks - Global Strategic Business Report - Product Image

Biobanks - Global Strategic Business Report

  • Report
  • 402 Pages
  • Global
From
Biobanking Market Size, Share, Trends and Forecast by Specimen Type, Biobank Type, Application, End-User, and Region, 2026-2034 - Product Image

Biobanking Market Size, Share, Trends and Forecast by Specimen Type, Biobank Type, Application, End-User, and Region, 2026-2034

  • Report
  • 144 Pages
  • Global
From
Biobank Automation Systems Market Report 2026 - Product Image

Biobank Automation Systems Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Biobank Equipment Market Report 2026 - Product Image

Biobank Equipment Market Report 2026

  • Report
  • 250 Pages
  • Global
From

About the Biobank Market

The Biobank market is a subset of the biotechnology industry that focuses on the collection, storage, and distribution of biological samples for research purposes. These samples can include human tissue, blood, and other bodily fluids, as well as plant and animal tissue. The biobank market is driven by the need for high-quality biological samples for research and development in the biotechnology industry. Biobanks are used to store and distribute biological samples for a variety of research purposes, including drug discovery, diagnostics, and personalized medicine. They are also used to store and distribute samples for clinical trials and epidemiological studies. The biobank market is highly competitive, with a number of companies offering services such as sample collection, storage, and distribution. Some of the major players in the market include Thermo Fisher Scientific, Qiagen, BioStorage Technologies, and Brooks Life Sciences. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.